Efficacy of insulin targeted gene therapy for type 1 diabetes mellitus: A systematic review and meta-analysis of rodent studies

Iranian Journal of Basic Medical Sciences

Maryam Miraghajani¹  Seyed Mohammad Bagher Tabei²  Leila Norouzi Barough³  Sima Jafarpour³  Zohreh Amirkhani³  Moosa Rahimi Ghiasi³  Elnaz Rahimi³  Ahmad Reza Salehi³  Rasoul Salehi⁴  Hamed Mohammadi⁵  Michael Symonds⁶ 

[1] Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

[2] 3 The Early Life Research Unit, Division of Child Health, Obstetrics and Gynaecology, and Nottingham Digestive Disease Centre and Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, UK;Department of Genetics & Maternal-Fetal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

[3] Gerfa Namayesh Azmayesh (GENAZMA) Science and Research Institute, Isfahan, Iran;Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran;The Early Life Research Unit, Division of Child Health, Obstetrics and Gynaecology, and Nottingham Digestive Disease Centre and Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, UK;

关键词: gene therapy;    insulin;    meta-analysis;    non-viral vector;    type 1 diabetes mellitus;    viral vector;   

DOI  :  10.22038/ijbms.2020.39470.9359

来源: DOAJ

【 摘 要 】

Objective(s): Diabetes mellitus (DM) is a major worldwide public health challenge, for which gene therapy offers a potential therapeutic approach. To date, no systematic review or meta-analysis has been published in this area, so we examined all relevant published studies on rodents to elucidate the overall effects of gene therapy on bodyweight, intraperitoneal glucose tolerance test (IPGTT), fasting blood glucose, and insulin in animals with type 1 DM.
Materials and Methods: The Cochrane Library, PubMed, Embase, ISI Web of Science, SCOPUS, and Google Scholar were systematically searched for potentially relevant studies. Mean±standard deviation (SD) was pooled using a random-effects model.
Results: After the primary search, out of 528 studies identified, 16 studies were in concordance with predefined criteria and selected for the final assessment. Of these, 12 studies used viral manipulation, and 4 employed non-viral vectors for gene delivery. The meta-analysis showed gene therapy with a viral vector decreased mean IPGTT (-12.69 mmol/l, P<0.001), fasting blood glucose (-13.51 mmol/l, P<0.001), insulin (398.28 pmol/l, P<0.001), and bodyweight (24.22 g, P<0.001), whereas non-viral vectors reduced fasting glucose (-29.95 mmol/l, P<0.001) and elevated insulin (114.92 pmol/l, P<0.001).
Conclusion: Gene therapy has favorable effects on alleviating type 1 DM related factors in diabetic rodents.

【 授权许可】

Unknown